ASAHI GLASS CO (SHJ MU) stock market data APIs
€34.0393
0(0%)
as of February 11, 2026
Try our APIs with
free plan!
ASAHI GLASS CO Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for SHJ.MU.
Prev. Close
34.0393
Open
34.0393
High
34.0393
Low
34.0393
52 wk Range
23.5593-34
Market Cap
9 674 M
Dividends (Yield)
6
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get ASAHI GLASS CO data using free add-ons & libraries
Get ASAHI GLASS CO Fundamental Data
ASAHI GLASS CO Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-02-06
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
ASAHI GLASS CO News
New
Enginzyme and AGC Create Scalable Process for Key mRNA Ingredient
STOCKHOLM, January 12, 2026--(BUSINESS WIRE)--At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-meth...
Is Corning a Strong Bet for Investors on Gorilla Glass Innovations?
Corning Incorporated (GLW) is increasingly focusing on expanding its Gorilla Glass portfolio through continuous innovations and R&D. The Gorilla Glass Ceramic 2 is a next-generation transparent glass-...
AGC’s Regenerative Medicine Partnership Might Change the Case for Investing in AGC (TSE:5201)
Celaid Therapeutics Inc. announced that it has entered a collaborative research agreement with AGC Inc. to advance iPS cell-derived hematopoietic stem and progenitor cells, aiming to address manufactu...
Celaid Therapeutics have executed a collaborative research agreement with AGC on Expansion and Functional Evaluation of iPSC-HSPCs
TOKYO, Aug. 28, 2025 /PRNewswire/ -- Celaid Therapeutics Inc. ("Celaid") have executed a collaborative research agreement with AGC Inc. ("AGC") to advance iPS cell-derived hematopoietic stem and proge...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
